MIR3189

Across TCGA pan-cancer cohorts, MIR3189 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of MIR3189’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR3189 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR3189 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC, COAD, and KICH are the cancer types where MIR3189 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3189 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	IV	−2.199	<.001	12	view →
COAD	Male	IV	+3.494	<.001	11	view →
KICH	Female	II,III,IV	−3.242	<.001	11	view →
THCA	Male	All	+3.311	<.001	10	view →
STAD	Male	II,III,IV	+1.947	<.001	6	view →
UCEC	All	All	+1.626	<.001	6	view →
BRCA	Female	All	+0.615	<.001	6	view →
LUAD	All	All	+1.186	<.001	5	view →
CHOL	All	All	+3.163	.002	3	view →
KIRP	All	All	−1.061	.006	3	view →
READ	Female	All	+2.936	.010	2	view →
PRAD	All	All	+1.675	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

MIR3189–KIRC

Open the KIRC breakdown →